Preclinical Strategies and Models in Oncology

For more details on the conference, please contact:

Marina Filshtinsky, MD

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-5496

Email: mfilshtinsky@healthtech.com

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Email: reymael@healthtech.com

Register Early for Maximum Savings

October 17

Emerging Immune Modulation Strategies NEW

October 18-19

PROTACs and Molecular Glues
– Part 1

Target Identification and Validation
– Part 1

Targeting RNA

Small Molecule Immuno-Oncology Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

Targeting KRAS and Other Small G Proteins

Artificial Intelligence in Drug Discovery – Part 1NEW

October 19-20

PROTACs and Molecular Glues
– Part 2

Target Identification and Validation
– Part 2

New Antivirals NEW

NASH and Fibrosis

Neurodegeneration Targets NEW

Antibodies Against Membrane Protein Targets – Part 2

Drug Lead Generation Strategies

Artificial Intelligence in Drug Discovery – Part 2 NEW